In cisplatin-induced nephropathy, treatment with the flavonoid baicalein decreased renal injury and downregulated the activation of MAPKs and NF-κB by inducing Nrf2 nuclear translocation [168]. This evidence concerns the gene NFE2L2 and kidney disorder.